Tsuchiura, Japan

Atsushi Nomoto

This inventor holds 1 USPTO granted patent. Top assignee: Fujisawa Pharmaceutical Company, Ltd.. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Atsushi Nomoto. Retrieved from https://idiyas.com/inventor/atsushi-nomoto

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 64(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Atsushi Nomoto: Innovator in cGMP-PDE Inhibitors

Introduction

Atsushi Nomoto is a notable inventor based in Tsuchiura, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds.

Latest Patents

Nomoto holds a patent for "Indole derivatives as cGMP-PDE inhibitors." This invention showcases his expertise in creating compounds that have potential therapeutic applications.

Career Highlights

He is associated with Fujisawa Pharmaceutical Company, Ltd., where he has been instrumental in advancing research and development efforts. His work has contributed to the company's reputation in the pharmaceutical industry.

Collaborations

Nomoto has collaborated with esteemed colleagues, including Teruo Kyoto Oku and Kozo Sawada. These partnerships have fostered a collaborative environment that enhances innovation.

Conclusion

Atsushi Nomoto's contributions to the field of pharmaceuticals, particularly through his patent on cGMP-PDE inhibitors, highlight his role as a key innovator. His work continues to influence the industry and pave the way for future advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…